WE CARE FOR SUSTAINABLE SUCCESS
The management team at Curetis combines many years of experience and expertise in the fields of product development, regulatory approvals, business development and marketing. Our managers have wide-ranging experience in the fields of in-vitro diagnostics (IVD), medical technology, financing, M&A transactions and partnerships with international companies. Our skills profile is completed by the relevant expertise with regard to commercializing molecular diagnostic tests, including the international approval procedures.
In spite of the company's continuous growth, the way in which we think and act is still greatly influenced by our founders. Our founders actively contribute to the company in an operational capacity, and work together with over 70 employees at two locations in Germany as well as an international sales and applications specialist team to drive a process of continuous improvement in all areas.
OLIVER SCHACHT, PHD, CEO
Following a long-standing career with Epigenomics AG (1998–2011), Oliver Schacht, an expert in the diagnostics industry, has been CEO of Curetis since 2011. He was a co-founder and CFO of Epigenomics AG in Berlin and CEO of the US subsidiary Epigenomics Inc. (Seattle, USA). Oliver has extensive experience in developing and implementing commercial strategies and financing measures (including an IPO), as well as in finance, M&A transactions and alliance negotiations. Oliver obtained his Diploma in European Business Administration at the European School of Business in Reutlingen and London in 1994 as well as a master's degree and a PhD at the University of Cambridge (UK). During his time at Mercer Management Consulting (1995–1999), he worked on projects in the fields of M&A, growth strategies and reorganization in the pharmaceutical, biotechnology and other industries.
Johannes Bacher – COO
Johannes Bacher combines almost 20 years of R&D and managerial experience with extensive expertise in the fields of international project management, finance, human resources, legal affairs and the design of organizational structures. Hence, the Curetis co-founder is ideally suited to managing the general business activity of Curetis. Johannes has a degree in electrical engineering and has already worked for several international medical technology companies, including Hewlett Packard, Agilent and Philips Medical Systems.
Andreas Boos – CTO
With over 25 years of professional experience at Hewlett Packard, Agilent and Philips, Curetis co-founder Andreas Boos boasts a wealth of international experience in developing and implementing solutions for patient monitoring and on-site molecular diagnostics. As a graduate electrical engineer, Andreas Boos has successfully applied his project management skills to lead the development of several innovative and commercially successful medical devices for the global markets. In addition to his extensive knowledge of customer requirements, Andreas brings to Curetis a comprehensive understanding of quality systems, standards and global regulatory approval procedures.
Dr. Achim Plum – CCO
Achim Plum joined Curetis in 2015 as Chief Commercial Officer overseeing all commercial activities including global marketing and sales, business development and medical affairs. He joined from a senior management position with Siemens where he was responsible for the assessment and development of novel approaches to the in vitro diagnostics market. Prior to Siemens, Achim worked for eight years with the publicly traded German-American molecular diagnostics company Epigenomics AG, most recently as Senior Vice President Business and Strategy. At Epigenomics he built sales and marketing teams and distribution networks in Europe and the U.S., negotiated strategic commercial agreements with leading diagnostics industry players and led the company’s corporate communications and compliance functions. Following undergraduate studies at the University of Bonn (Germany) and the University of East Anglia in Norwich (UK), Achim obtained his PhD in molecular genetics from the University of Bonn in 1999 for developing and studying novel genetic models of human diseases.
Heiko Schorr – Director Finance
Heiko Schorr has worked for Curetis as Director Finance since March 2012. He has nearly 20 years of professional experience in various roles with increasing managerial responsibility in the fields of accounting, taxes, finances and controlling. In his career to date, Heiko Schorr has already established and managed teams of employees in large corporations and in medium-sized high-tech companies. He has introduced ERP systems (Navision) as well as budgeting and reporting systems for various locations and international offices. Heiko has extensive specialist expertise thanks to his previous positions as Head of Finance & Controlling at Betec Electronic GmbH and as Intercompany Accountant at Yves Rocher GmbH. Heiko Schorr has a degree (IFRS economist) from Nürtingen University of Applied Sciences, is a certified accountant (Reutlingen Chamber of Commerce) and completed training to become a tax consultant at Stuttgart Chamber of Tax Consultants.
Christopher Bernard – President & CEO Curetis USA, Inc.
Chris Bernard has joined Curetis as President & CEO of Curetis USA, Inc. He has more than 22 years of experience in the diagnostics and biopharmaceutical industry as well as in the translational research, including roles in senior executive management, strategic development, product commercialization, marketing and sales. Prior to joining Curetis, Chris had been the Chief Commercial Officer at Epic Sciences and responsible for the expansion of Epic’s technology. Prior to Epic Sciences, he was Senior Vice President, Sales and Marketing and an officer at Metabolon Inc and Vice President and Officer at Abaxis Inc. At Abaxis he had been responsible for sales and marketing of the point-of-care diagnostics platform Piccolo Xpress®. He began his career at Cytyc Corporation (Hologic Inc.) where he was regional business director responsible for growth in sales and management of a portfolio of diagnostic products, including the ThinPrep® Pap Test and Imager and NovaSure® endometrial ablation. Chris Bernard holds a BA in psychobiology from Hiram College, Ohio, USA where he also sits on the board of the entrepreneurial leadership program.
Willem Haagmans – Head of Sales EMEA
Willem Haagmans has joined the company as Head of Sales for the EMEA region in February 2016. He has previously worked at Beckman Coulter as General Manager Benelux. He is a highly experienced commercial executive with a strong track record, including the successful commercialization of innovative products and solutions in the molecular diagnostics industry as well as the significant increase of top-line revenue growth. Among others, Willem Haagmans has held prior international molecular diagnostics sales management positions with Roche, Nimblegen, and Vela Diagnostics, bringing extensive leadership experience with both large and small-to-medium sized molecular diagnostics companies. He is based in the Venlo area near the Dutch-German border, right at the heart of Curetis’ European direct sales territories, and will head all direct sales efforts in DACH, Benelux, France, UK and possibly Nordic countries.
Dr. Sandra Burrack-Lange - Head of Marketing
Dr. Sandra Burrack-Lange joined Curetis in October 2011, initially as a Clinical Application Specialist in our marketing team. During the past 4 years she took over various project management roles in branding, marketing and launch of Unyvero nationally as well as internationally. Since January 2015 Sandra Burrack-Lange has taken over all strategic and operational marketing aspects as our Head of Marketing at Curetis. In addition to several years of R & D activities, Dr. Sandra Burrack-Lange has many years of extensive experience in classical microbiology and virology. At Strathmann Biotec she worked in R&D roles for the pharmaceutical industry.
Dr. Helmut Hilbert – Head of Business Development
Dr. Helmut Hilbert has been working for Curetis as Head of Business Development since 2013. Prior to this position, he was employed by Qiagen as Associate Director of Corporate Business Development. In addition to seven years of R&D activities, Dr. Helmut Hilbert has more than ten years' experience in business and corporate development, and has an impressive track record in the fields of licensing, mergers & acquisitions, technology transfer and innovation management. At Qiagen, Helmut was responsible for assessing new technologies and evaluating acquisition candidates and investment opportunities. His responsibilities also included contract negotiations, due diligence and the integration of acquired companies and technologies.
Dr. Gerd Luedke – Director Assay Development
Dr. Gerd Luedke is able to look back on a twenty-year career in the field of assay development for research and for analytical and diagnostic systems. He has experience in heading up international projects in multiple locations. He has been responsible for the design of molecular diagnostic assays and the development of clinical applications. Prior to co-founding Curetis, Gerd had worked as a project manager for microfluidics systems at Agilent Technologies as well as for test development at Philips Medical Systems. Dr. Gerd Luedke obtained a doctorate in lung cancer tumor biology at Zurich University Hospital and studied Technical Biology at the University of Stuttgart.
Dr. med. Anne Thews – Medical Director
Prior to joining Curetis, Dr. med. Anne Thews worked as Marketing Manager at Philips Medical Systems. Prior to that, she held international managerial positions in marketing and in sales support at Beckman Coulter. During her 20-year career, she has gained extensive experience in strategic and tactical clinically oriented marketing and is regarded as a respected expert within the key industry networks. As a Curetis co-founder, Anne plays an important role within the team, bringing professional experience as a marketing specialist in conjunction with her international experience as a trained doctor (internist) and as the long-standing manager of a clinical diagnostic laboratory (University Hospital of Mainz).
Kay Scherer - Head of Quality and Regulatory Affairs
Before joining the Curetis Team in October 2010, Kay had been a senior QM Engineer at Abbott Vascular in Germany. He was the Lead Auditor of the international vendor program and participated in several transfer and development projects. (sterile medical devices, class III) within an FDA and CE regulated market until market introduction of the products. Additionally, he was the group leader of the metrology team. Kay has a strong background in GMP, ISO and QSR regulated industry. Kay graduated as a pharmaceutical engineer and has been trained as a six sigma black belt.
At Curetis, Kay holds the position as the Head of Quality and Regulatory Affairs and is responsible for maintaining and developing the global QM System, the worldwide product registrations and QC of Curetis products.
Bernd Bleile, Ass.iur. - General Counsel
Bernd Bleile has joined Curetis as General Counsel in February 2016. He is responsible for all legal affairs within Curetis, including general legal advice, workshops and trainings on legal topics, contract preparation and review, foundation and legal support of subsidiaries, contact for external lawyers, to appear in court etc. Prior to Curetis, he worked in the area of law at “SMARTRAC”, a leading RFID product developing and manufacturing company, and at a former subsidiary of Daimler “MercedesBenz Technologies” in Sindelfingen. He qualified as a lawyer and graduated as Master of Public Management (Dipl. Verwaltungswirt/FHöV - Rentenversicherung) at the University of Tübingen, University of Applied Sciences Ludwigsburg and German Federal Pension Fund Baden-Württemberg. In addition, he qualified as in-house data protection officer at TÜV-Süd.